The use of danazol in the management of endometriosis

M D Young, Young MD, Blackmore WP, W P Blackmore
The Journal of international medical research · 1977 · PMID:913886
other public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This paper reviews the use of danazol in managing endometriosis by examining its efficacy, side effects, and proposed mechanisms of action.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Pelvic Neoplasms Pregnadienes Danazol Danazol Danazol Endometriosis Endometriosis Female Follicle Stimulating Hormone Follicle Stimulating Hormone Humans Luteinizing Hormone Luteinizing Hormone Menstruation Menstruation Pelvic Neoplasms Pelvic Neoplasms Pregnadienes

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-06T06:10:23.601157+00:00
pubmed
last seen: 2026-05-14T05:58:58.463083+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine